Search PubMed⌕ Search

Biomedical subjects

J Styrud

Publications and source records attributed to J Styrud.

20 records · Page 2Linked to original sources

Congenital malformations in diabetic pregnancy: the clinical relevance of experimental animal studies.

The aim of this work was to present recent observations on the occurrence of malformations in the offspring of diabetic rats and to discuss these findings in the light of present clinical experience. Comparison of malformation rates between different substrains of Sprague-Dawley rats showed marked differences in the occurrence of diabetes-induced malformations. These findings suggest that congenital malformations in diabetic pregnancy may result from a teratological insult in genetically predisposed individuals. Recent clinical reports seem to link facial malformations to an increased incidence of sacral-caudal malformations in human diabetic pregnancy. The present rat model, which expresses both these aberrations--micrognathia and sacral dysgenesis--may therefore be a useful tool in studies of the aetiological relationships between disturbed maternal metabolism and skeletal malformations in the offspring. Malformations in fetuses of diabetic animals seem to arise from teratogenic insult(s) early in pregnancy. Hyperglycemia and hyperketonemia may both singly, and in combination, be of teratological significance. Insulin itself does not appear to be directly teratogenic. Furthermore, there is evidence to suggest that disturbed levels of trace metals, primarily zinc, may be a significant factor in the production of congenital malformations. The increased rate of malformations in diabetic pregnancy, therefore, appears to be multifactorial in origin.

Animals↗

Retrospective analysis of the efficacy of cefotaxime sodium dosed twice daily. The Swedish experience.

In a Swedish multicenter, comparative, retrospective study, patients with different types of infections--bacteremia-septicemia, genitourinary, intra-abdominal, central nervous system, and lower respiratory tract infections--were randomly selected from the hospital records. Patients treated with cefotaxime twice or three times a day as monotherapy (excluding metronidazole) for at least 1 day (240 cases) were analyzed in terms of clinical and bacteriologic outcome, these results were correlated with the dosing regimen. Similarly high success rates (cure and improvement) at hospital discharge were observed in both group initially treated with cefotaxime 1 g twice daily and 2 g twice daily (97 and 96%, respectively). A total of 73% of patients were initially treated with cefotaxime for only 3 days at most before changing to a lower dose regimen, an alternate intravenous treatment, or oral drug follow-up. Clinical evaluation at hospital discharge revealed a clinical success rate between 87 and 100%, depending on the type of infection.

Adolescent↗